日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / State Council News

Nation issues new anti-monopoly guidelines for pharma sector

By Li Jiaying | chinadaily.com.cn | Updated: 2025-01-24 21:04
Share
Share - WeChat
Pharmacists dispense drugs at a hospital in Huzhou, Zhejiang province, in August. YI FAN/FOR CHINA DAILY

In an effort to safeguard fair market competition and protect consumer interests, the State Council's anti-monopoly commission officially issued new anti-monopoly guidelines on Friday targeting the pharmaceutical sector. 

A key highlight of the guidelines lies in the involvement of online platforms' monopolistic regulations. Given the rapid growth of online medical consultations and pharmaceutical e-commerce, the guidelines, for the first time, incorporate measures to address monopolistic practices in online medicine businesses, prohibiting platforms from engaging in the misuse of data, algorithms or platform rules.

The broad scope of the new guidelines also merits attention, which encompasses the entire pharmaceutical product chain — including traditional Chinese medicine, chemical drugs and biological products — compared to the previous version, which was largely concentrated in the limited realm of chemical active pharmaceutical ingredients (APIs).

"The pharmaceutical industry is highly technology-driven. Besides APIs, it also includes innovative drugs, patented medicines and generics. Every stage — from procurement and R&D to production, distribution and generic development — involves significant technological advancements and related protective strategies," said Zhou Wei, deputy director of the health law research center at Wuhan University, in an earlier interview. 

To further combat "false innovation", the guidelines also address a new type of patent monopoly behavior known as "product hopping". 

Product hopping refers to a strategy employed by original drug manufacturers to avoid or reduce competition from generic drugs, which mostly occurs shortly before the expiration of a patented drug and the entry of its generic counterpart and if applied inappropriately, could constitute an abuse of market dominance.

Factors for evaluation include whether the new patented drug represents a non-substantial improvement and whether the transition hinders or delays the entry of generics into the market, according to the guidelines.

"This is not about restricting the development of patented drugs but about regulating false innovation that fails to significantly improve a drug's efficacy, safety or utility," Zhou said.

Comprising seven chapters and 55 articles, the guidelines aim to provide detailed interpretations of monopolistic practices, enforcement principles and criteria for determining violations, offering a comprehensive framework to tackle anti-competitive behaviors in the pharmaceutical industry.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 精品久久久久久久久久 | 天天操天天操天天 | 精品美女在线观看视频在线观看 | 久久色婷婷 | 日本a级大片 | 久草福利资源网站免费 | 欧美国产激情二区三区 | 久久精品国产精品青草图片 | 久久久久国产成人精品亚洲午夜 | 日韩视频第二页 | 成人福利在线视频免费观看 | 国产精品久久久久久久一区探花 | 国内色综合精品视频在线 | 久久久久久久综合日本亚洲 | 久草福利在线视频 | 亚洲精品色 | 午夜视频在线免费观看 | 久草97| 精品视频一区二区三区在线播放 | 亚洲欧洲另类 | 久久se精品一区精品二区 | 亚洲精品国产不卡在线观看 | 精品伊人久久久大香线蕉欧美 | 清纯唯美亚洲综合激情 | www.中文字幕在线观看 | 国产精品美女www爽爽爽视频 | 久久在线视频 | 新封神榜杨戬电影免费动画在线观看国语 | 天天插天天爽 | av在线免费观看播放 | 亚洲欧洲精品一区二区 | 浮力影院草草影院 | 亚洲午夜精品一区二区 | 国产欧美一区二区三区免费看 | 一级毛片视频播放 | 久草经典视频 | 新版天堂资源中文在线 | 成人免费福利 | 久久我们这里只有精品国产4 | 日本一区视频在线播放 | 视频福利在线观看 |